Latest Articles
Mucin Biology as a Local Diagnostic and Promising Therapeutic Target in Endometriosis: Expression and Glycosylation Profiling.
Endometriosis (EM) is a chronic inflammatory disease characterized by the growth of endometrial-like tissue outside the uterus, yet its molecular mechanisms remain poorly understood. This study investigated the expression of …
Published: Jan. 20, 2026, midnight
Correction: Endometriosis burden and trends among women of childbearing age from 1990 to 2021.
[This corrects the article DOI: 10.3389/fendo.2025.1561673.].
Published: Jan. 20, 2026, midnight
Endometriosis beyond the pelvis: Insights from atypical presentations leading to diagnostic delays.
Published: Jan. 20, 2026, midnight
‘I’ve lost my life’: Alberta woman forced to seek endometriosis care abroad amid years-long wait lists - Global News
‘I’ve lost my life’: Alberta woman forced to seek endometriosis care abroad amid years-long wait lists Global News
Published: Jan. 19, 2026, 11:53 p.m.
Providence Minute: Undersanding Endometriosis - kobi5.com
Providence Minute: Undersanding Endometriosis kobi5.com
Published: Jan. 19, 2026, 5:50 p.m.
'Clear as mud' application process for endometriosis treatment putting women off, advocates say - Irish Examiner
'Clear as mud' application process for endometriosis treatment putting women off, advocates say Irish Examiner
Published: Jan. 19, 2026, 4 p.m.
Updated guidance highlights unmet needs in endometriosis care - European Medical Journal
Updated guidance highlights unmet needs in endometriosis care European Medical Journal
Published: Jan. 19, 2026, 3:59 p.m.
Chronic pelvic pain and endometriosis affect thousands in NZ—a new study reveals the staggering cost - Medical Xpress
Chronic pelvic pain and endometriosis affect thousands in NZ—a new study reveals the staggering cost Medical Xpress
Published: Jan. 19, 2026, 3:38 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - BIOENGINEER.ORG
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment BIOENGINEER.ORG
Published: Jan. 19, 2026, 3:06 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - Bioengineer.org
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment Bioengineer.org
Published: Jan. 19, 2026, 3:06 p.m.
Link copied to clipboard!